ARTICLE | Financial News
Lexicon raises $130M in follow-on and notes
November 22, 2014 2:24 AM UTC
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) raised $80 million through the sale of senior convertible notes and $50 million in a follow-on through the sale of 49.8 million shares at $1. JP Morgan; Goldman Sachs; Needham; and Stifel, Nicolaus are underwriters.
The notes bear 5.25% interest, mature in 2021 and initially convert at $1.21. ...